Recombinant Human IL-1 RII Protein, CF
Catalog # 263-2R/CF | R&D Systems, Inc. a Bio-Techne Brand
Key Product Details
Product Specifications
Source
Phe14-Glu343
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
Approximately 1-5 µg/mL of IL- sRII will inhibit 50% of the biological response due to 50 pg/mL of recombinant human IL-1 beta.
Formulation, Preparation and Storage
263-2R/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 250 μg/mL in sterile PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: IL-1 RII
Two distinct types of receptors that bind the pleiotropic cytokines IL-1 alpha and IL-1 beta have been described. The IL-1 receptor type I is an 80 kDa transmembrane protein that is expressed predominantly by T cells, fibroblasts and endothelial cells. IL-1 receptor type II is a 68 kDa transmembrane protein found on B lymphocytes, neutrophils, monocytes, large granular leukocytes and endothelial cells. Both receptors are members of the immunoglobulin superfamily and show approximately 28% sequence similarity in their extracellular domains. The two receptor types do not heterodimerize in a receptor complex.
An IL-1 receptor accessory protein (1) that can heterodimerize with the type I receptor in the presence of IL-1 alpha or IL-1 beta but not IL-1ra, was identified. This type I receptor complex appears to mediate all the known IL-1 biological responses. The receptor type II has a short cytoplasmic domain and does not transduce IL-1 signals. In addition to the membrane-bound form of IL-1 RII, a naturally-occurring soluble form of IL-1 RII has been described. It has been suggested that the type II receptor, either as the membrane-bound or as the soluble form, serves as a decoy for IL-1 and inhibits IL-1 action by blocking the binding of IL-1 to the signaling type I receptor complex. Recombinant IL-1 soluble receptor type II is a potent antagonist of IL-1 action.
Product Documents for Recombinant Human IL-1 RII Protein, CF
Product Specific Notices for Recombinant Human IL-1 RII Protein, CF
For research use only
Citations for Recombinant Human IL-1 RII Protein, CF (4)
Citations are publications that use Bio-Techne products. Selected citations for Recombinant Human IL-1 RII Protein, CF include:
-
Sample Types: Protein
Applications: Surface Plasmon ResonanceIssafras H et al. (2013-11-05), Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1beta antibody with differential receptor-modulating properties. J Pharmacol Exp Ther, 2013-1348(1):202-15.
PMID: 24194526 -
Species: Complex Species Category
Sample Types: In Vivo
Applications: In VivoKhoufache K et al. (2012-07-27), Soluble human IL-1 receptor type 2 inhibits ectopic endometrial tissue implantation and growth: identification of a novel potential target for endometriosis treatment. Am J Pathol, 2012-0181(4):1197-205.
PMID: 22841820 -
Sample Types: N/A
Applications: Antibody Absorption,Western BlotHerrmann-Lavoie C et al. (2007-08-16), Chorionic gonadotropin down-regulates the expression of the decoy inhibitory interleukin 1 receptor type II in human endometrial epithelial cells. Endocrinology, 2007-0148(11):5377-84.
PMID: 17702847 -
Sample Types: N/A
Applications: ELISA (Standard)Emsley HC et al. (2007-02-28), Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC Neurol, 2007-07(0):5.
PMID: 17328808
There are no citations that match your criteria.
Reconstitution Calculator
The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.